Palliative care is not just about dying – patients who access it in the early stages of an illness live longer and with better quality of life
All news from Anaesthesiology
Researchers from Karolinska Institutet and Kancera AB have developed a molecule that makes cancer cells sensitive to radiotherapy. In a study published in Nature Communications, the researchers describe a new way to block cancer cells' ability to repair their DNA and thus stop the survival of cancer cells.
Magnetic resonance imaging (MRI) positive for sacroiliitis is seen in a considerable number of healthy individuals without back pain, according to a study recently published in Arthritis & Rheumatology
Prime Minister Narendra Modi launched the world's biggest health insurance scheme, promising free coverage for half a billion of India's poorest citizens ahead of national elections next year.
States serve as “laboratories of democracy,” as U.S. Supreme Court Justice Louis Brandeis famously said. And states are also labs for health policy, launching all kinds of experiments lately to temper spending on pharmaceuticals.
Collagen from a marine resource is believed to have more potential activity in bone tissue engineering and their bioactivity depends on biochemical and structural properties.
If you have ever broken an arm and had to wear a cast or splint for a few weeks, you will be familiar with the alarming loss of muscle and uneasy feeling of weakness experienced after removing your cast
When the Canadian Olympic women's field hockey team was preparing for the 2016 games in Rio de Janeiro, a team of researchers from the University of British Columbia and Simon Fraser University had an idea. They wanted to determine if heat stress could enhance the athletes' performance by increasing the volume of plasma in their blood. In order to find out, they asked the athletes to undertake six days of hot yoga immediately before a six-day training camp.
Against the backdrop of an unrelenting opioid crisis, two new government reports warn that America's seniors are succumbing to the pitfalls of prescription painkillers.
A new study in the Journal of Neurology finds that pregabalin is not effective in controlling the chronic pain that sometimes develops following traumatic nerve injury. The results of the international study, which was driven by an effort to identify effective non-opioid pain medications, did show potential in relieving in pain that sometimes lingers after surgery.
Alector, a privately held biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration, announced the initiation of its Phase 1 trial called INFRONT, which is evaluating AL001, the company's product candidate for the treatment of a genetically-defined sub-population of patients with frontotemporal dementia (FTD).